KYNB Delisted from Nasdaq Global Select Market; $50M Asset/Revenue Requirement Missed; 45-Day Plan Due May 18 2026; Potential Transfer to Nasdaq Capital Market
Kyntra Bio, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.90
-4.9% since the alert
$7.19 → $6.84
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS